Adaptimmune Therapeutics plc

  • Home
  • Our Company
    • Overview arrow_forward
    • Partners arrow_forward
    • Board of Directors arrow_forward
    • Leadership Team arrow_forward
    • Scientific Advisory Board arrow_forward
    • Perspectives arrow_forward
    • COVID-19 arrow_forward
  • Pipeline
    • Overview arrow_forward
    • ADP-A2M4 arrow_forward
    • ADP-A2M4CD8 arrow_forward
    • ADP-A2AFP arrow_forward
    • ADP-A2M10 arrow_forward
  • Technology
    • Overview arrow_forward
    • Manufacturing arrow_forward
    • Publications arrow_forward
  • Patients & Families
    • Overview arrow_forward
    • Taking Part in Our Clincial Trials arrow_forward
    • Cancer Info arrow_forward
    • Cancer Immunotherapy Month arrow_forward
    • Videos arrow_forward
    • Engagement with Patient Organizations arrow_forward
  • Clinical Trials
  • Investors & Media
    • Overview arrow_forward
    • News & Events arrow_forward
    • Annual Shareholder Meeting arrow_forward
    • Company Info arrow_forward
    • Financial Info arrow_forward
    • Stock Data arrow_forward
    • SEC Filings arrow_forward
    • Governance arrow_forward
    • Media arrow_forward
  • Contact
  • Careers
    • Overview arrow_forward
    • US Careers arrow_forward
    • UK Careers arrow_forward

Presentations

Investors & Media

Investors & Media

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Annual Shareholder Meeting
  • Company Info
    • Overview
    • Leadership Team
    • Board of Directors
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Media
  • Company Info

  • Overview
  • Leadership Team
  • Board of Directors
  • Presentations
  • Contacts
  • FAQ
January 2018 Presentation
Jan 8, 2018

January 2018 Presentation

Media Backgrounder
Jan 5, 2018

Media Backgrounder

Q3 2017 Adaptimmune Earnings Conference Call Transcript
Nov 2, 2017

Q3 2017 Adaptimmune Earnings Conference Call Transcript

September/October 2017 Corporate Presentation
Sep 28, 2017

September/October 2017 Corporate Presentation

GlaxoSmithKline PLC Exercises Option Over Adaptimmune Therapeutics PLC's SPEAR T-cell Therapy Program Targeting NY-ESO Call Transcript
Sep 7, 2017

GlaxoSmithKline PLC Exercises Option Over Adaptimmune Therapeutics PLC's SPEAR T-cell Therapy Program Targeting NY-ESO Call Transcript

July 2017 Corporate Presentation
Jul 5, 2017

July 2017 Corporate Presentation

June 2017 Corporate Presentation: ASCO
Jun 6, 2017

June 2017 Corporate Presentation: ASCO

April 2017 Corporate Presentation
Apr 10, 2017

April 2017 Corporate Presentation

March 2017 Corporate Presentation: Jefferies
Mar 30, 2017

March 2017 Corporate Presentation: Jefferies

March 2017 Corporate Presentation
Mar 13, 2017

March 2017 Corporate Presentation

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Adaptimmune Therapeutics plc
Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms
Linedin Twitter Youtube
© 2021 Adaptimmune Therapeutics plc. All Rights Reserved.